Medical Care

Global Non Small Cell Lung Cancer Treatment Market Research Report 2025

The global market for Non Small Cell Lung Cancer Treatment was valued at US$ 166 million in the year 2024 and is projected to reach a revised size of US$ 306 million by 2031, growing at a CAGR of 9.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non Small Cell Lung Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non Small Cell Lung Cancer Treatment.
The Non Small Cell Lung Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non Small Cell Lung Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non Small Cell Lung Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Pfizer Inc
Sanofi
F. Hoffmann-La Roche Ltd
Astrazeneca
Eli Lilly and Company
Merck & Co Inc
Bristol-Myers Squibb Company
Celgene Corporation
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non Small Cell Lung Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Non Small Cell Lung Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non Small Cell Lung Cancer Treatment Market Perspective (2020-2031)
2.2 Global Non Small Cell Lung Cancer Treatment Growth Trends by Region
2.2.1 Global Non Small Cell Lung Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non Small Cell Lung Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Non Small Cell Lung Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Non Small Cell Lung Cancer Treatment Market Dynamics
2.3.1 Non Small Cell Lung Cancer Treatment Industry Trends
2.3.2 Non Small Cell Lung Cancer Treatment Market Drivers
2.3.3 Non Small Cell Lung Cancer Treatment Market Challenges
2.3.4 Non Small Cell Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non Small Cell Lung Cancer Treatment Players by Revenue
3.1.1 Global Top Non Small Cell Lung Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Non Small Cell Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non Small Cell Lung Cancer Treatment Revenue
3.4 Global Non Small Cell Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global Non Small Cell Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non Small Cell Lung Cancer Treatment Revenue in 2024
3.5 Global Key Players of Non Small Cell Lung Cancer Treatment Head office and Area Served
3.6 Global Key Players of Non Small Cell Lung Cancer Treatment, Product and Application
3.7 Global Key Players of Non Small Cell Lung Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non Small Cell Lung Cancer Treatment Breakdown Data by Type
4.1 Global Non Small Cell Lung Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Non Small Cell Lung Cancer Treatment Breakdown Data by Application
5.1 Global Non Small Cell Lung Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non Small Cell Lung Cancer Treatment Market Size (2020-2031)
6.2 North America Non Small Cell Lung Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non Small Cell Lung Cancer Treatment Market Size (2020-2031)
7.2 Europe Non Small Cell Lung Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Non Small Cell Lung Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non Small Cell Lung Cancer Treatment Market Size (2020-2031)
9.2 Latin America Non Small Cell Lung Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Non Small Cell Lung Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Non Small Cell Lung Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Non Small Cell Lung Cancer Treatment Introduction
11.2.4 Pfizer Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.2.5 Pfizer Inc Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Non Small Cell Lung Cancer Treatment Introduction
11.3.4 Sanofi Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.4.5 F. Hoffmann-La Roche Ltd Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Non Small Cell Lung Cancer Treatment Introduction
11.5.4 Astrazeneca Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Non Small Cell Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.6.5 Eli Lilly and Company Recent Development
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Company Details
11.7.2 Merck & Co Inc Business Overview
11.7.3 Merck & Co Inc Non Small Cell Lung Cancer Treatment Introduction
11.7.4 Merck & Co Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.7.5 Merck & Co Inc Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Non Small Cell Lung Cancer Treatment Introduction
11.9.4 Celgene Corporation Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025)
11.9.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy
Table 5. Global Non Small Cell Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non Small Cell Lung Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Non Small Cell Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2020-2025)
Table 9. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2026-2031)
Table 11. Non Small Cell Lung Cancer Treatment Market Trends
Table 12. Non Small Cell Lung Cancer Treatment Market Drivers
Table 13. Non Small Cell Lung Cancer Treatment Market Challenges
Table 14. Non Small Cell Lung Cancer Treatment Market Restraints
Table 15. Global Non Small Cell Lung Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Non Small Cell Lung Cancer Treatment Market Share by Players (2020-2025)
Table 17. Global Top Non Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2024)
Table 18. Ranking of Global Top Non Small Cell Lung Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Non Small Cell Lung Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Non Small Cell Lung Cancer Treatment, Headquarters and Area Served
Table 21. Global Key Players of Non Small Cell Lung Cancer Treatment, Product and Application
Table 22. Global Key Players of Non Small Cell Lung Cancer Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Non Small Cell Lung Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Non Small Cell Lung Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Non Small Cell Lung Cancer Treatment Product
Table 50. Novartis AG Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Pfizer Inc Company Details
Table 53. Pfizer Inc Business Overview
Table 54. Pfizer Inc Non Small Cell Lung Cancer Treatment Product
Table 55. Pfizer Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 56. Pfizer Inc Recent Development
Table 57. Sanofi Company Details
Table 58. Sanofi Business Overview
Table 59. Sanofi Non Small Cell Lung Cancer Treatment Product
Table 60. Sanofi Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. F. Hoffmann-La Roche Ltd Company Details
Table 63. F. Hoffmann-La Roche Ltd Business Overview
Table 64. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Product
Table 65. F. Hoffmann-La Roche Ltd Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd Recent Development
Table 67. Astrazeneca Company Details
Table 68. Astrazeneca Business Overview
Table 69. Astrazeneca Non Small Cell Lung Cancer Treatment Product
Table 70. Astrazeneca Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 71. Astrazeneca Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Product
Table 75. Eli Lilly and Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Merck & Co Inc Company Details
Table 78. Merck & Co Inc Business Overview
Table 79. Merck & Co Inc Non Small Cell Lung Cancer Treatment Product
Table 80. Merck & Co Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 81. Merck & Co Inc Recent Development
Table 82. Bristol-Myers Squibb Company Company Details
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Product
Table 85. Bristol-Myers Squibb Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Celgene Corporation Company Details
Table 88. Celgene Corporation Business Overview
Table 89. Celgene Corporation Non Small Cell Lung Cancer Treatment Product
Table 90. Celgene Corporation Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 91. Celgene Corporation Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report


List of Figures
Figure 1. Non Small Cell Lung Cancer Treatment Picture
Figure 2. Global Non Small Cell Lung Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non Small Cell Lung Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Non Small Cell Lung Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Non Small Cell Lung Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Non Small Cell Lung Cancer Treatment Report Years Considered
Figure 13. Global Non Small Cell Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Non Small Cell Lung Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Non Small Cell Lung Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Non Small Cell Lung Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Non Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Non Small Cell Lung Cancer Treatment Revenue in 2024
Figure 19. North America Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 49. Pfizer Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 52. Astrazeneca Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 54. Merck & Co Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies